These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3410263)

  • 21. [Dynamics of arterial pressure and gas exchange in dogs with acute blood loss replaced by an emulsion of carbon tetrafluoride].
    Akhsianov UU; Afonin NI; Troitskiĭ VB
    Gematol Transfuziol; 1983 Apr; 28(4):41-4. PubMed ID: 6852512
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical application of fluorocarbon artificial blood in 10 cases (author's transl)].
    Xiong RC
    Zhonghua Wai Ke Za Zhi; 1981 Apr; 19(4):213-5. PubMed ID: 7261781
    [No Abstract]   [Full Text] [Related]  

  • 23. The structure-property correlation: estimates of the half-clearance time of perfluororganic compounds.
    Golovanov IB; Ivanitskii GR; Tsygankova IG; Khabarova MI
    Dokl Biochem; 2000; 371(1-6):63-8. PubMed ID: 10853453
    [No Abstract]   [Full Text] [Related]  

  • 24. Development and clinical application of perfluorochemical artificial blood.
    Ohyanagi H; Saitoh Y
    Int J Artif Organs; 1986 Sep; 9(5):363-8. PubMed ID: 3781670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical potential of intravenously administered perfluorocarbons.
    Habler O; Kleen M; Messmer K
    Acta Anaesthesiol Scand Suppl; 1997; 111():256-8. PubMed ID: 9421036
    [No Abstract]   [Full Text] [Related]  

  • 26. [Characteristics of the body oxygen supply when replacing blood loss of moderate severity with an emulsion of perfluoroorganic compounds and with polyglucin].
    Iarochkin VS; Volos OP; Koziner VB
    Gematol Transfuziol; 1986 Jun; 31(6):43-7. PubMed ID: 2426156
    [No Abstract]   [Full Text] [Related]  

  • 27. [The corrective effect of perfluorocarbon emulsions on the cerebral hemodynamics in craniocerebral trauma].
    Krivoshapkin AL; Krivoshapkin AL; Semenycheva TV
    Zh Vopr Neirokhir Im N N Burdenko; 1992; (6):17-9. PubMed ID: 1337408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Indices of oxygen supply to the bodies of rats following blood replacement by a perfluorodecalin emulsion].
    Chaplygina ZA; Kuznetsova IN; Domracheva VS; Gokhman NSh; Maksimov BN
    Biull Eksp Biol Med; 1980 Nov; 90(11):546-8. PubMed ID: 6778535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New transfusion strategies: red cell substitutes.
    Winslow RM
    Annu Rev Med; 1999; 50():337-53. PubMed ID: 10073282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Half-life of perfluorooctylbromide in inner organs determined by fast 19F-NMR imaging.
    Jäger LJ; Nöth U; Haase A; Lutz J
    Adv Exp Med Biol; 1994; 361():129-34. PubMed ID: 7597935
    [No Abstract]   [Full Text] [Related]  

  • 31. Influence of perflubron emulsion particle size on blood half-life and febrile response in rats.
    Keipert PE; Otto S; Flaim SF; Weers JG; Schutt EA; Pelura TJ; Klein DH; Yaksh TL
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1169-74. PubMed ID: 7849919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluosol-DA as a red-cell substitute in acute anemia.
    Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Langdale LA; Krause LM; Rice CL; Chamberlin WH; Moss GS
    N Engl J Med; 1986 Jun; 314(26):1653-6. PubMed ID: 3713771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emulsions of perfluorochemicals as blood substitutes.
    Sloviter HA; Mukherji B
    Acta Anaesthesiol Belg; 1984; 35 Suppl():61-8. PubMed ID: 6516760
    [No Abstract]   [Full Text] [Related]  

  • 34. The use of fluorocarbon emulsions in cancer radiotherapy.
    Guichard M
    Radiother Oncol; 1991; 20 Suppl 1():59-64. PubMed ID: 2020771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of the perfluorocarbon Fluosol-DA in coronary angioplasty.
    Kerins DM
    Am J Med Sci; 1994 Mar; 307(3):218-21. PubMed ID: 8160713
    [No Abstract]   [Full Text] [Related]  

  • 36. Fluosol-DA as a red-cell substitute in acute anemia.
    N Engl J Med; 1986 Dec; 315(26):1677-8. PubMed ID: 3785341
    [No Abstract]   [Full Text] [Related]  

  • 37. Preparation of perfluorodecalin emulsion, an approach to the red cells substitute.
    Yokoyama K; Yamanouchi K; Watanabe M; Matsumoto T; Murashima R; Daimoto T; Hamano T; Okamoto H; Suyama T; Watanabe R; Naito R
    Fed Proc; 1975 May; 34(6):1478-83. PubMed ID: 1126445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Which is the foreseeable clinical application of oxygen-carrying blood substitutes (fluorocarbons and hemoglobin solutions)? Which impact are they likely to have on the activity of blood services?
    Vox Sang; 1982 Feb; 42(2):97-109. PubMed ID: 7064434
    [No Abstract]   [Full Text] [Related]  

  • 39. The use of perfluorochemicals in the treatment of acute cerebral ischemia.
    Peerless SJ
    Prog Clin Biol Res; 1983; 122():353-62. PubMed ID: 6410404
    [No Abstract]   [Full Text] [Related]  

  • 40. Retention of perfluorochemicals in rat liver and spleen.
    Lowe KC; Bentley PK
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):1029-31. PubMed ID: 1391422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.